Fam20b Knockout MC3T3-E1 Cell Line

The Fam20b Knockout MC3T3-E1 Cell Line is a CRISPR/Cas9-edited knockout cell line designed for investigating gene function in pre-osteoblast biology. This model features targeted disruption of Fam20b, providing a genetically defined loss-of-function system. The MC3T3-E1 cell line, derived from newborn mouse calvaria, is an established in vitro model for osteoblast differentiation and extracellular matrix maturation. By eliminating Fam20b expression, researchers can systematically study its role in glycosaminoglycan biosynthesis and skeletal development. This validated knockout line is supplied ready-to-use for bone biology research.

The MC3T3-E1 cell line, derived from newborn mouse calvaria, is a well-characterized pre-osteoblast model that undergoes sequential differentiation into mature osteoblasts upon stimulation. These cells recapitulate key stages of osteogenesis, including matrix deposition and mineralization, making them ideal for dissecting molecular regulators of bone formation. This line has been widely employed to study the effects of genetic perturbations on osteoblast function and extracellular matrix production. In the context of Fam20b knockout, the MC3T3-E1 background provides a relevant environment to assess how loss of this kinase affects proteoglycan synthesis and subsequent mineralization defects.

Fam20b encodes a Golgi kinase that phosphorylates xylose in the proteoglycan linkage region, a rate-limiting step for glycosaminoglycan chain polymerization. This phosphorylation is essential for the addition of galactose and glucuronic acid by B3GAT3 and B4GALT7, enabling elongation of glycosaminoglycan chains. Fam20b functions downstream of osteogenic cues, including Runx2 transcriptional activity and BMP/Wnt signaling, and acts upstream of proteoglycan assembly and extracellular matrix organization. It interacts with glycosyltransferases EXTL2 and EXTL3, highlighting its central role in glycosaminoglycan biosynthesis.

Disruption of Fam20b in MC3T3-E1 cells recreates critical aspects of skeletal dysplasia and bone mineralization defects observed in vivo. Since Fam20b is essential for proteoglycan production, its knockout severely impairs the formation of aggrecan and other matrix proteoglycans, leading to defective osteoblast differentiation and matrix calcification. This model thus enables detailed mechanistic studies of how glycosaminoglycan deficiencies contribute to neonatal lethality and skeletal malformations. It provides a tractable system for screening modifiers of the glycosaminoglycan pathway and testing interventions that might rescue proteoglycan synthesis or osteoblast function.

The Fam20b Knockout MC3T3-E1 Cell Line is suitable for a range of applications, including bone development studies, osteoblast differentiation assays, glycosaminoglycan quantification, and extracellular matrix research. Representative techniques include alizarin red staining and ALP assays to assess mineralization, Western blotting and RT-qPCR for target validation, and immunofluorescence to visualize proteoglycan distribution. Researchers can employ this model to explore the interplay between glycosaminoglycan biosynthesis and signaling pathways such as Wnt and BMP, as well as to screen small molecules that modulate proteoglycan production. For further inquiries regarding product specifications or ordering, please contact Ascent Research.